Annual EBIT:
-$101.86M-$53.69M(-111.45%)Summary
- As of today (October 4, 2025), DNTH annual earnings before interest & taxes is -$101.86 million, with the most recent change of -$53.69 million (-111.45%) on December 31, 2024.
- During the last 3 years, DNTH annual EBIT has fallen by -$27.17 million (-36.38%).
- DNTH annual EBIT is now -999.09% below its all-time high of -$9.27 million, reached on December 1, 2016.
Performance
DNTH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$34.93M-$1.75M(-5.27%)Summary
- As of today (October 4, 2025), DNTH quarterly earnings before interest & taxes is -$34.93 million, with the most recent change of -$1.75 million (-5.27%) on June 30, 2025.
- Over the past year, DNTH quarterly EBIT has dropped by -$12.72 million (-57.30%).
- DNTH quarterly EBIT is now -625.98% below its all-time high of -$4.81 million, reached on March 1, 2017.
Performance
DNTH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$129.92M-$12.72M(-10.86%)Summary
- As of today (October 4, 2025), DNTH TTM earnings before interest & taxes is -$129.92 million, with the most recent change of -$12.72 million (-10.86%) on June 30, 2025.
- Over the past year, DNTH TTM EBIT has dropped by -$61.16 million (-88.94%).
- DNTH TTM EBIT is now -2600.48% below its all-time high of -$4.81 million, reached on March 1, 2017.
Performance
DNTH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DNTH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -111.5% | -57.3% | -88.9% |
| 3Y3 Years | -36.4% | -93.2% | -61.8% |
| 5Y5 Years | -22.8% | -74.5% | -54.2% |
DNTH EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -242.9% | at low | -354.6% | at low | -238.3% | at low |
| 5Y | 5-Year | -242.9% | at low | -354.6% | at low | -238.3% | at low |
| All-Time | All-Time | -999.1% | at low | -626.0% | at low | -2600.5% | at low |
DNTH EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$34.93M(+5.3%) | -$129.92M(+10.9%) |
| Mar 2025 | - | -$33.18M(+4.0%) | -$117.20M(+15.1%) |
| Dec 2024 | -$101.86M(+111.5%) | -$31.92M(+6.7%) | -$101.86M(+22.9%) |
| Sep 2024 | - | -$29.90M(+34.7%) | -$82.90M(+20.6%) |
| Jun 2024 | - | -$22.20M(+24.4%) | -$68.76M(+17.9%) |
| Mar 2024 | - | -$17.84M(+37.7%) | -$58.34M(+21.1%) |
| Dec 2023 | -$48.17M(+62.2%) | -$12.96M(-17.8%) | -$48.17M(+4.9%) |
| Sep 2023 | - | -$15.76M(+33.8%) | -$45.91M(+19.5%) |
| Jun 2023 | - | -$11.78M(+53.3%) | -$38.41M(-14.1%) |
| Mar 2023 | - | -$7.68M(-28.1%) | -$44.71M(-26.5%) |
| Dec 2022 | -$29.70M(-60.2%) | -$10.69M(+29.5%) | -$60.86M(-13.4%) |
| Sep 2022 | - | -$8.25M(-54.4%) | -$70.31M(-12.4%) |
| Jun 2022 | - | -$18.08M(-24.1%) | -$80.30M(+0.6%) |
| Mar 2022 | - | -$23.83M(+18.3%) | -$79.83M(+6.9%) |
| Dec 2021 | -$74.69M | - | - |
| Dec 2021 | - | -$20.14M(+10.4%) | -$74.69M(+1.5%) |
| Sep 2021 | - | -$18.25M(+3.6%) | -$73.62M(-0.2%) |
| Jun 2021 | - | -$17.61M(-5.8%) | -$73.75M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$18.70M(-1.9%) | -$76.16M(-3.2%) |
| Dec 2020 | -$78.70M(-5.1%) | -$19.07M(+3.7%) | -$78.70M(-6.6%) |
| Sep 2020 | - | -$18.38M(-8.2%) | -$84.27M(-4.8%) |
| Jun 2020 | - | -$20.01M(-5.8%) | -$88.54M(+0.8%) |
| Mar 2020 | - | -$21.24M(-13.8%) | -$87.86M(+5.9%) |
| Dec 2019 | -$82.97M(+38.4%) | -$24.64M(+8.8%) | -$82.97M(+8.8%) |
| Sep 2019 | - | -$22.64M(+17.1%) | -$76.26M(+8.4%) |
| Jun 2019 | - | -$19.34M(+18.3%) | -$70.32M(+8.2%) |
| Mar 2019 | - | -$16.35M(-8.8%) | -$65.01M(+8.4%) |
| Dec 2018 | -$59.96M(+67.8%) | -$17.93M(+7.4%) | -$59.96M(+42.7%) |
| Sep 2018 | - | -$16.70M(+19.1%) | -$42.03M(+29.9%) |
| Jun 2018 | - | -$14.03M(+24.0%) | -$32.35M(-5.0%) |
| Mar 2018 | - | -$11.31M(+61.2%) | -$34.05M(+23.6%) |
| Dec 2017 | -$35.73M(+285.5%) | - | - |
| Sep 2017 | - | -$7.01M(-55.4%) | -$27.56M(+34.1%) |
| Jun 2017 | - | -$15.73M(+227.0%) | -$20.54M(+327.0%) |
| Mar 2017 | - | -$4.81M | -$4.81M |
| Dec 2016 | -$9.27M | - | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual EBIT year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Dianthus Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. TTM EBIT year-on-year change?
What is Dianthus Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of DNTH is -$101.86M
What is the all-time high annual EBIT for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$9.27M
What is Dianthus Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, DNTH annual earnings before interest & taxes has changed by -$53.69M (-111.45%)
What is Dianthus Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of DNTH is -$34.93M
What is the all-time high quarterly EBIT for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$4.81M
What is Dianthus Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, DNTH quarterly earnings before interest & taxes has changed by -$12.72M (-57.30%)
What is Dianthus Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of DNTH is -$129.92M
What is the all-time high TTM EBIT for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$4.81M
What is Dianthus Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, DNTH TTM earnings before interest & taxes has changed by -$61.16M (-88.94%)